Markets:

Overview

News

Currencies

International

Treasuries

Evolus, Inc. - Common Stock (NQ:EOLS)

4.300 +0.020 (+0.47%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Evolus, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗

January 21, 2025

Via Benzinga

A Closer Look at 5 Analyst Recommendations For Evolus ↗

October 03, 2024

Via Benzinga

Analyst Scoreboard: 4 Ratings For Evolus ↗

September 13, 2024

Via Benzinga

EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 ↗

July 31, 2024

EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early ↗

July 31, 2024

The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.

Via Investor's Business Daily

Evolus: Chiseling Away At The Aesthetic Market ↗

May 25, 2024

Via Talk Markets

Recap: Evolus Q4 Earnings ↗

March 07, 2024

Via Benzinga

Earnings Outlook For Evolus ↗

March 06, 2024

Via Benzinga

AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ↗

February 14, 2024

A Relative Strength Rating upgrade for AbbVie shows improving technical performance.

Via Investor's Business Daily

EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 02, 2024

Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 21, 2024

Via Benzinga

EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings ↗

February 01, 2024

Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level.

Via Investor's Business Daily

Earnings Preview: Evolus ↗

August 01, 2023

Via Benzinga

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 29, 2024

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped...

Via Benzinga

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday ↗

January 29, 2024

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported...

Via Benzinga

Topics Stocks

Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker ↗

January 17, 2024

Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 17, 2024

Via Benzinga

Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition ↗

January 11, 2024

AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing...

Via Benzinga

December 12, 2023

Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to...

Via Benzinga

Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday ↗

November 08, 2023

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 08, 2023

Via Benzinga

Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 07, 2023

Via Benzinga

7 Must-Own Small-Cap Stocks That Could Outperform the Market ↗

October 08, 2023

If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you.

Via InvestorPlace

7 Small-Cap Stocks Analysts Predict Will Double in 2024 ↗

September 13, 2023

While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.

Via InvestorPlace

Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying ↗

August 16, 2023

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Evolus, Inc. - Common Stock (NQ:EOLS)

Headline News about Evolus, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today